
|Articles|April 27, 2003
Treatment advances for overactive bladder 'pushing the therapeutic index'
Chicago-Some researchers investigating the physiology and treatment ofoveractive bladder have questioned whether a "therapeutic ceiling"has been reached with anticholinergic medications, the current mainstayof treatment. Although the balance between efficacy and tolerability ofanticholinergics falls short of ideal, a number of products under developmenthold promise, said Roger Dmochowski, MD, professor of urology at VanderbiltUniversity School of Medicine in Nashville, TN.
Advertisement
Newsletter
Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
Mark Tyson, MD shares promising BOND-003 results in papillary NMIBC
2
CORE-008: Cretostimogene achieves high CR rate in high-risk NMIBC
3
Gemcitabine intravesical system delivers high 12-month DFS in papillary-only NMIBC
4
Choosing salvage therapy after prostate cancer focal ablation
5


















